Andy Plump teams with MD An­der­son on the race to cell ther­a­py 2.0 — and they’re al­ready plan­ning a piv­otal

Take­da R&D chief Andy Plump has picked his con­tender in the race to cre­ate cell ther­a­py 2.0, and he’s cre­at­ed his own break­through on­col­o­gy path to hus­tle it through a near-term piv­otal.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER